Shulph Ink
Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies
Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies
YOU SAVE £18.84
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Couldn't load pickup availability
Excellent- More about Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies
Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies is a comprehensive resource that provides insights into the development of novel sensitizers for anti-EGFR targeted antibody therapies in cancer. It covers strategies for rational design and discovery, translational studies, and clinical trial methodology.
Format: Hardback
Length: 256 pages
Publication date: 25 November 2022
Publisher: Elsevier Science Publishing Co Inc
Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies is a comprehensive exploration of the sensitizers employed to overcome resistance to anti-EGFR targeted antibody therapies in cancer. This book delves into the landscape of anti-EGFR based cancer treatments, highlighting the challenges and potential future advancements in antibody therapy. It provides valuable insights into the rational design and discovery of novel sensitizing agents, as well as translational studies involving pre-clinical and clinical design.
As an indispensable resource for cancer researchers, medicinal chemists, and other biomedical scientists, this book offers a wealth of scientific information on strategies used for the rational design and discovery of novel sensitizing agents. It also encompasses translational studies involving pre-clinical and clinical design, providing valuable insights into the translation of research findings into clinical applications.
Furthermore, the book covers basic science strategies used in drug discovery and preclinical evaluation focused on EGFR blockage resistance, as well as clinical trial methodology, including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new anticancer sensitizers for anti-EGFR drug resistance.
By presenting a comprehensive overview of the latest developments in this field, Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies serves as a valuable tool for researchers, clinicians, and healthcare professionals seeking to enhance the effectiveness of anti-EGFR targeted antibody therapies in cancer treatment.
Dimension: 235 x 191 (mm)
ISBN-13: 9780128215845
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
